Kalaris Therapeutics (KLRS) Shares Issued (2020 - 2026)
Kalaris Therapeutics (KLRS) posted quarterly Shares Issued of $740341.0 for Q1 2026, down 35.33% year-over-year from $1.1 million in Q1 2025, and down 65.44% quarter-over-quarter from $2.1 million in Q4 2025.
Kalaris Therapeutics (KLRS) Shares Issued (2020 - 2026) Analysis & Trends
Kalaris Therapeutics' Shares Issued history runs 5 years deep, the most recent figure standing at $740341.0 for Q1 2026.
- In Q1 2026, Shares Issued fell 35.33% year-over-year to $740341.0; the TTM figure through Mar 2026 stood at $740341.0 (down 35.33% YoY), while the FY2025 annual figure was $2.1 million, changed N/A from the prior year.
- Shares Issued for Q1 2026 stood at $740341.0, down from $2.1 million in the prior quarter.
- The five-year high for Shares Issued was $6.7 million in Q1 2022, with the low at $740341.0 in Q1 2026.
- The 3-year median for Shares Issued is $2.1 million (2025), against an average of $3.9 million.
- The sharpest annual moves came in 2022 and 2026: Shares Issued changed 0.0% in 2022, then slumped 35.33% in 2026.
- Kalaris Therapeutics' Shares Issued stood at $6.7 million in 2022, then tumbled by 68.1% to $2.1 million in 2025, then tumbled by 65.44% to $740341.0 in 2026.
- Business Quant data shows KLRS's Shares Issued at $740341.0 in Q1 2026, $2.1 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Kalaris Therapeutics | 100.19 Mn | 100.19 Mn | - | 2.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.54 Mn |
| Jun 30, 2026 | 2.54 Mn |
| Mar 31, 2026 | 740,341.00 |
| Mar 31, 2026 | 740,341.00 |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.08 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Sep 30, 2022 | 6.72 Mn |
| Sep 30, 2022 | 6.72 Mn |
| Jun 30, 2022 | 6.72 Mn |
| Jun 30, 2022 | 6.72 Mn |
| Mar 31, 2022 | 6.72 Mn |
| Mar 31, 2022 | 6.72 Mn |